Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soludia is a French pharmaceutical company specializing in the development and commercialization of products for gastroenterology, with a primary focus on bowel preparation for diagnostic procedures. The company achieved significant recognition for developing Colokit, the first bowel-cleansing agent available in tablet form, which offered a more convenient and patient-friendly alternative to traditional high-volume liquid preparations. Founded in 2001, Soludia established itself as an innovator in galenic formulation to improve patient compliance during colonoscopies. In 2014, the company was acquired by Mayoly (formerly Mayoly Spindler), a leading independent French pharmaceutical group, to strengthen its digestive health portfolio. Today, Soludia's products continue to be marketed under the Mayoly umbrella, benefiting from an expanded international distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soludia.